MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HP-11-0005450
Siraigo Pharma Private Limited
Siraigo Pharma Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2 Cr
▲ 37% YoY
Net profit · FY 2024
₹2.66 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹14.37 Lakh
EBITDA margin 7.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.77 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
About Siraigo Pharma Private Limited
Data last updated:
Siraigo Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC146558. Its GSTIN is 02AAICS2958J2Z5 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.77 Lakh. It is led by directors Balvinder Kaur and Naresh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No.13 Sector – 17 Kopar Khairane, Navi Mumbai, Maharashtra, India – 400709.
As per the financials filed for FY 2024, the company reported a revenue of ₹2 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹2.66 Lakh (net margin 1.3%) and EBITDA of ₹14.37 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹60 Lakh on record.
Siraigo Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0005450). The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN U24230MH2004PTC146558
Registration Number 146558
Incorporation Date 26 May 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-HP-11-0005450
Key People
Balvinder Kaur Director Naresh Kumar Director Recognitions & Rankings of Siraigo Pharma
Contact details
Siraigo Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressBlock No.13 Sector – 17 Kopar Khairane, Navi Mumbai, Maharashtra, India – 400709
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Siraigo Pharma Private Limited, buy the company report.
Comprehensive company report
Siraigo Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Siraigo Pharma is manufacturing. In detail, this covers manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 16 | Manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials |
To see the full business activity and turnover split of Siraigo Pharma Private Limited, buy the company report.
Financials of Siraigo Pharma Private Limited
FY 2025 filings availableSiraigo Pharma Private Limited reported revenue of ₹2 Cr (up 37% YoY) for FY 2024.
Revenue · FY 2024
₹2 Cr ▲ 37%
Net profit · FY 2024
₹2.66 Lakh margin 1.3%
EBITDA · FY 2024
₹14.37 Lakh margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 33%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 1%
5 years · compounded
▼ 2%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 37% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Siraigo Pharma Private Limited, buy the company report.
Board of directors of Siraigo Pharma Private Limited
Siraigo Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balvinder Kaur | Director | 05 Jul 2017 | 9 Years 3 Months | Current |
| Naresh Kumar | Director | 05 Jul 2017 | 9 Years 3 Months | Current |
Auditor
Siraigo Pharma Private Limited is audited by KARNAIL SINGH & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KARNAIL SINGH & CO | FY 2019 | 024416N |
Shareholding
The shareholding of Siraigo Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Siraigo Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹60 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2017 | 100096836 | State Bank of India | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Siraigo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siraigo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Siraigo Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAICS2958J2Z5 | Himachal Pradesh | Active | 26 Feb 2018 |
To see the full GST registrations and return filing status of Siraigo Pharma Private Limited, buy the company report.
Recent activity
Siraigo Pharma Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Pushpendra Singh ceased to be Director on 02 Aug 2017.
AGM
Siraigo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Siraigo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Pushpendra Singh ceased to be Director.
Appointed
Balvinder Kaur was appointed as Director.
Appointed
Naresh Kumar was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 60.00 Lakh with Charge ID 100096836 was registered on 25 Apr 2017.
Ceased
Vinod Kumar ceased to be Additional Director.
Ceased
Ankit Mittal ceased to be Director.
Ceased
Om Prakash Gupta ceased to be Director.
Ceased
Radhey Shyam Mittal ceased to be Director.
Incorporation
26 May 2004
Siraigo Pharma Private Limited was registered on 26 May 2004 with Roc Mumbai Ii & aged 22 years 5 months as per MCA records.
Frequently asked questions
Siraigo Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 2004 (22+ years old) and is registered under CIN U24230MH2004PTC146558.
Siraigo Pharma has 2 current directors:
- Balvinder Kaur - Director
- Naresh Kumar - Director
The latest financial statements of Siraigo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Siraigo Pharma is 02AAICS2958J2Z5, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Siraigo Pharma is U24230MH2004PTC146558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siraigo Pharma was incorporated on 26 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Pushpendra Singh ceased to be Director on 02 Aug 2017. Balvinder Kaur was appointed as Director on 05 Jul 2017. Naresh Kumar was appointed as Director on 05 Jul 2017. Siraigo Pharma has 7 board changes on record in total.
Yes, Siraigo Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-11-0005450).
The registered office of Siraigo Pharma is at Block No.13 Sector – 17 Kopar Khairane, Navi Mumbai, Maharashtra, India – 400709.
Siraigo Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.